Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet

Proteomics

Volumn 12, Issue 9, 2012, Pages 1437-1451

  Thomas, Anja ^a   Stevens, Axel P ^a,c   Klein, Matthias S ^a   Hellerbrand, Claus ^b   Dettmer, Katja ^a   Gronwald, Wolfram ^a   Oefner, Peter J ^a   Reinders, Jörg ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

Author keywords

Animal proteomics; Liver proteome; Metabolomics; Nonalcoholic steatohepatitis; Two dimensional differential in gel electrophoresis

Indexed keywords

CHOLESTEROL; LIVER SOLUBLE PROTEOME; METHIONINE; PROTEOME; S ADENOSYLMETHIONINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; IMMUNOBLOTTING; LIFESTYLE; MASS SPECTROMETRY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANALYSIS OF VARIANCE; ANIMALS; CHOLESTEROL; DIET; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FATTY LIVER; FEMALE; GLYCEROL; IMMUNOHISTOCHEMISTRY; LIVER; METABOLOMICS; MICE; MICE, INBRED C57BL; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; S-ADENOSYLMETHIONINE;

ANIMALIA; MUS;

EID: 84861145151     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100628     Document Type: Article

References (61)

1. Bellentani, S., Scaglioni, F., Marino, M., Bedogni, G., Epidemiology of non-alcoholic fatty liver disease. Dig. Dis. 2010, 28(1), 155-161.
2. Basaranoglu, M., Kayacetin, S., Yilmaz, N., Kayacetin, E. et al., Understanding mechanisms of the pathogenesis of non-alcoholic fatty liver disease. World J. Gastroenterol. 2010, 14, 2223-2226.
3. Day, C. P., James, O.F., Steatohepatitis: a tale of two "hits"? Gastroenterology 1998, 114, 842-845.
4. Fromenty, B., Robin, M. A., Igoudjil, A., Mansouri, A. et al., The ins and outs of mitochondrial dysfunction. Diabetes Metab. 2004, 30, 121-138.
5. Caldwell, S. H., Crespo, D. M., Kang, H. S., Al-Osaimi, A. M. S., Obesity and hepatocellular carcinoma. Gastroenterology 2004, 127, S97-S103.
6. Bugianesi, E., Manzini, P., D'Antico, S., Vanni, E. et al., Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in non-alcoholic fatty liver. Hepatology 2004, 39, 179-187.
7. Reddy, J. K., Rao, M. S., Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, 852-858.
8. Charlton, M., Sreekumar, R., Rasmussen, D., Lindor, K. et al., Apolipoprotein synthesis in non-alcoholic steatohepatitis. Hepatology 2002, 35, 898-904.
9. Anstee, Q. M., Goldin, R. D., Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 2006, 87, 1-16.
10. Vergnes, L., Phan, J., Strauss, M., Tarufi, S. et al., Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J. Biol. Chem. 2003, 278(44), 42774-42784.
11. Kalhan, S. C., Guo, L., Edmison, J., Dasarathy, S. et al., Plasma metabolic profile in non-alcoholic fatty liver disease. Metabolism 2011, 60(3), 404-413.
12. Younossi, Z. M., Baranova, A., Ziegler, K., Del Giacco, L. et al., A genomic and proteomic study of the spectrum of non-alcoholic fatty liver disease. Hepatology 2005, 42, 665-674.
13. Baranova, A., Liotta, L., Petricoin, E., Younossi, Z. M., The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease. Clin. Liver Dis. 2007, 11, 209-220.
14. Ulukaya, E., Yilmaz, Y., Moshkovskii, S., Karpova, M. et al., Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Scand. J. Gastoenterol. 2009, 44, 1471-1476.
15. Cobbold, J. F., Anstee, Q. M., Goldin, R. D., Williams, H. R. et al., Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clin. Sci. (Lond.) 2009, 116, 403-413.
16. Santamaria, E., Avila, M. A., Latasa, M. U., Rubio, A. et al., Functional proteomics of non-alcoholic steatohepatitis: mitochondrial proteins as a target of S-adenosylmethionine. Proc. Natl. Acad. Sci. USA 2003, 100, 3065-3070.
17. Desai, M. S., Mariscalco, M. M., Tawil, A., Vallejo, J. G. et al., Atherogenic diet-induced hepatitis is partially dependent on murine TLR4. J. Leukoc. Biol. 2008, 83, 1336-1344.
18. Heitzmann, D., Derand, R., Jungbauer, S., Bandulik, S. et al., Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralcorticoid homeostasis. EMBO J. 2008, 27, 179-187.
19. Lillie, R. D., Pizzolato, P., Donaldson, P. T., Nuclear stains with soluble metachrome mordant lake dyes. The effect of chemical endgroup blocking reactions and the artificial introduction of acid groups into tissues. Histochemistry 1976, 49, 23-35.
20. Bligh, E. G., Dyer W. J., A rapid method for total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37, 911-917.
21. Dorn, C., Riener, M. O., Kirovski, G., Saugspier, M. et al., Expression of fatty acid synthase in nonalcoholic fatty liver disease. Int. J. Clin. Exp. Pathol. 2010, 25, 505-514.
22. Klein, M. S., Dorn, C., Saugspier, M., Hellerbrand, C. et al., Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy. Metabolomics 2010, 7(2), 237-246.
23. Stevens, A. P., Dettmer, K., Kirovski, G., Samejima, K. et al., Quantification of intermediates of the methionine and polyamine metabolism by liquid-chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies. J. Chromatogr. A 2010, 1217, 3282-3288.
24. Blum, H., Beier, H., Gross, H. J., Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987, 8, 93-99.
25. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
26. Dorn, C., Kraus, B., Motyl, M., Weiss, T. S. et al., Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. Mol. Nutr. Food Res. 2010, 54, S205-S213.
27. Gibonet, P. T., Mildly elevated liver transaminase levels in the asymptomatic patient. Am. Fam. Physician 2005, 71, 1105-1110.
28. Hellerbrand C., Mühlbauer, M., Wallner, S., Schuierer, M. et al., Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Carcinogenesis 2006, 27, 64-72.
29. Aranha, M. M., Bile acid levels are increased in the liver of patients with steatohepatitis. Eur. J. Gastoenterol. Hepatol. 2010, 20, 519-525.
30. Brunt, E. M., Nonalcoholic steatohepatitis: histopathological findings in NAFLD and NASH. Semin. Liver Dis. 2004, 24, 3-20.
31. Sanyal, A. J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W. B. et al., Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120, 1183-1192.
32. Li, L. O., Hu, Y.-F., Wang, L., Mitchell, M. et al., Early hepatic insulin resistance in mice: a metabolomics analysis. Mol. Endocrin. 2010, 24, 657-666.
33. Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker J. et al., NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35, 373-379.
34. Tilg, H., Moschen, A. R., Evolution of inflammation in non-alcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010, 52, 1836-1846.
35. Forbes, J. M., Coughlan, M. T., Cooper, M. E., Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008, 57, 1446-1454.
36. Nseir, W., Nassar, F., Assy, N., Soft drinks consumption and non-alcoholic fatty liver disease. World J. Gastroenterol. 2010, 16, 2579-2588.
37. Cano, A., Ciaffoni, F., Safwat, G. M., Aspichueta, P. et al., Hepatic VLDL assembly is disturbed in a rat model of non-alcoholic fatty liver disease: is there a role for dietary coenzyme Q? J. Appl. Physiol. 2009, 107, 707-717.
38. Zhang, X., Yang, J., Guo, Y., Ye, H. et al., Functional proteomic analysis of non-alcoholic fatty liver disease in rat models: enoyl-CoA hydratase downregulation exacerbates steatosis. Hepatology 2010, 51, 1-10.
39. Cheung, O., Sanyal, A. J., Abnormalities of lipid metabolism in non-alcoholic fatty liver disease. Semin. Liver Dis. 2008, 28, 351-359.
40. Fernandez, C., Krogh, M., Warell, K., Alm, K. et al., Omics analyses reveal a potential link between hormone-sensitive lipase and polyamine metabolism. J. Proteome Res. 2009, 8, 5008-5019.
41. Houstis, N., Rosen, E. D., Lander, E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440, 944-948.
42. Xia, W., Wang, Z., Wang, Q., Jin, H. et al., Roles of NAD+/NADH and NADP+/NADPH in cell death. Curr. Pharm. Des. 2009, 15, 12-19.
43. Takayama, F., Egashira, T., Kawasaki, H., Mankura, M. et al., A novel animal model of non-alcoholic steatohepatitis (NASH): hypoxemia enhances the development of NASH. J. Clin. Biochem. Nutr. 2009, 45, 335-340.
44. Serkova, N. J., Jackman, M., Brown, J. L., Liu, T. et al., Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol 2006, 44, 956-962.
45. Selhub, J., Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J. Nutr. Health Aging 2002, 6, 39-42.
46. Kinsell, L. W., Harper, H. A., Barton, H. C., Michaels, G. D. et al., Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science 1974, 106, 589-590.
47. Lu, S. C., Alvarez, L., Huang, Z. Z., Chen, L. et al., Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc. Natl. Acad. Sci. USA 2001, 98, 5560-5565.
48. Mato, J. M., Corrales, F. J., Lu, S. C., Avila, M. A., S-adenosylmethionine: a control switch which regulates liver function. FASEB J. 2002, 16, 15-26.
49. Lu, S. C., Mato, J. M., Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 2005, 35, 227-234.
50. She, Q. B., Nagao, I., Hayakawa, T., Tsuge, H., A simple HPLC method for the determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues: the effect of vitamin B6 deficiency on these concentrations in rat liver. Biochem. Biophys. Res. Commun. 1994, 205, 1748-1754.
51. Purohit, V., Abdelmalek, M. F., Barve, S., Benevenga, N. J. et al., Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am. J. Clin. Nutr. 2007, 86, 14-24.
52. Starkov, A. A., Fiskum, G., Chinopoulos, C., Lorenzo, B. J. et al., Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 2004, 24(36), 7779-7788.
53. Wortham, M., He, L., Gyamfi. M., Copple, B. L. et al., The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet. Dig. Dis. Sci. 2008, 53(10), 2761-2774.
54. Thomas, T., Thomas, T. J., Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell. Mol. Life Sci. 2001, 58, 244-258.
55. Scaglia, F., Brunetti-Pierri, N., Kleppe, S., Marini, J. et al., Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism. J. Nutr. 2004, 134, 2775S-2782S.
56. Kanehisha, M., Goto, S., Furumichi, M., Tanabe, M. et al., KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38, D355-D360.
57. Fujita, N., Miyachi, H., Tanaka, H., Takeo, M. et al., Iron overload is associated with hepatic oxidative damage to DNA in non-alcoholic steatohepatitis. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 424-432.
58. Petrak, J., Myslivcova, D., Man, P., Cmejla, R. et al., Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G1490-G1498.
59. Albano, E., Mottaran, E., Occhino, G., Reale, E. et al., Review article: role of oxidative stress in the progression of non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 2005, 22(Suppl 2), 71-73.
60. Alla, V., Bonkovsky, H. L., Iron in nonhemochromatotic liver disorders. Semin. Liver Dis. 2005, 25, 461-472.
61. Chitturi, S., George, J., Interaction of iron, insulin resistance, and non-alcoholic steatohepatitis. Curr. Gastroenterol. Rep. 2003, 5, 18-25.